Sol-Gel Technologies Ltd.

SLGLSEC EDGAR

Pharmaceutical Preparations(L3)CIK: 1684693

Concept	FY2024	FY2023	FY2022	FY2021	FY2020
Revenues	$3.9M	$31.3M	$8.8M	$22.9M	$129.0K
Research and Development Expense	$12.7M	$20.4M	$27.9M	$40.6M	$28.1M
Operating Income (Loss)	-$16.2M	$3.0M	-$30.2M	-$25.9M	-$33.5M
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	—	—	—	-$24.6M	-$32.2M
Income Tax Expense (Benefit)	—	—	—	$33.0K	$33.0K
Net Income (Loss) Attributable to Parent	-$14.9M	$3.2M	-$29.3M	-$24.6M	-$32.2M
Earnings Per Share, Basic	-$0.65	$0.14	-$1.30	-$1.26

Concept	FY2024	FY2023	FY2022	FY2021	FY2020
Assets	$45.3M	$46.6M	$69.2M	$59.2M	$61.3M
Assets, Current	$41.2M	$43.1M	$57.1M	$53.4M	$55.8M
Cash and Cash Equivalents, at Carrying Value	$12.4M	$20.1M	$7.1M	$9.4M	$5.3M
Accounts Receivable, after Allowance for Credit Loss, Current	$377.0K	$62.0K	—	—	—
Liabilities	$6.6M	$4.4M	$13.6M	$8.3M	$8.8M
Liabilities, Current	$4.5M	$3.3M	$11.7M	$6.0M	$6.5M
Accounts Payable, Current	—	—	—	$1.2M

Concept	FY2024	FY2023	FY2022	FY2021	FY2020
Net Cash Provided by (Used in) Operating Activities	-$9.5M	-$7.7M	-$25.2M	-$22.5M	-$23.5M
Net Cash Provided by (Used in) Investing Activities	$1.7M	$19.9M	-$2.7M	$16.0M	-$54.7M
Net Cash Provided by (Used in) Financing Activities	$15.0K	$837.0K	$26.5M	$10.6M	$78.8M
Payments to Acquire Property, Plant, and Equipment	$171.0K	$143.0K	$449.0K	$597.0K	$1.1M

Access SEC EDGAR data via REST API. Free tier available.

from sec_edgar import SecEdgar

api = SecEdgar("YOUR_KEY")
api.revenue("AAPL", limit=5)